RECRO PHARMA
Recro Pharma is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain, initially in the post-operative setting. The company's lead product, an intranasal formulation of Dexmedetomidine, or Dex, has completed a Phase Ib placebo-controlled trial demonstrating pain relief. It was founded in 2007 and headquartered in Malvern, Pennsylvania.
RECRO PHARMA
Social Links:
Industry:
Biotechnology Clinical Trials Health Care Pharmaceutical
Founded:
2007-01-01
Address:
Malvern, Pennsylvania, United States
Country:
United States
Website Url:
http://www.recropharma.com
Total Employee:
251+
Status:
Active
Contact:
(484) 395-2400
Email Addresses:
[email protected]
Total Funding:
226.5 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS Digital Ocean Mimecast QuoteMedia
Similar Organizations
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Ritter Pharmaceuticals
Ritter Pharmaceuticals discovers and commercializes treatments for gastrointestinal diseases.
Noveome Biotherapeutics
Noveome Biotherapeutics focuses on breakthrough therapies for the regenerative repair of inflamed or damaged tissues.
NuPathe
NuPathe is a pharmaceutical company developing solutions for diseases of the CNS, including neurological and psychiatric disorders.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Novita Pharmaceuticals
Novita Pharmaceuticals is a developer of therapeutic drugs for the treatment of cancer.
Neurana Pharmaceuticals
Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Viriom
Viriom is a clinical and commercial stage biotech developing drugs for treatment, prevention and cure of HIV and other infections.
Maxona Pharmaceuticals
Maxona is a pharmaceutical company that develops and commercializes a portfolio of novel therapeutics for the treatment of pain.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
MediGene
MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.
Laurent Pharmaceuticals
Laurent Pharmaceuticals is a private biopharmaceutical company developing a clinical stage, orally-active drug candidate.
Lumos Pharma
Lumos Pharma is a biopharmaceutical company that develops a novel treatment for the rare disease Creatine Transporter Deficiency.
Atlantic Healthcare
A rare disease pharmaceutical company acquiring, developing and commercializing therapeutics, specializing in gastroenterology.
Alexza Pharmaceuticals
Alexza Pharmaceuticals is a pharmaceutical company developing novel products for the treatment of acute and intermittent conditions.
Talphera
Talphera focuses on the development and commercialization of therapies for the treatment of pain and other conditions.
Aradigm
Aradigm is a pharmaceutical company focused on the development of drugs for the treatment of severe respiratory diseases.
Apexian Pharmaceuticals
Apex Therapeutics develops and commercializes pharmaceuticals for the treatment of cancer and ocular diseases.
Athersys
Athersys is a biopharmaceutical company that discovers and develops therapeutic products to treat several disease indications.
Aerial BioPharma
Aerial BioPharma is a biopharmaceutical company developing biologics and small molecules for central nervous system issues.
Agile Therapeutics
Agile Therapeutics is pharmaceutical company developing contraceptive healthcare products for women.
Alkermes
Alkermes is a biotechnology company that develops, manufactures and commercializes medicines for the treatment of chronic diseases.
Apricus Biosciences
Apricus Bio (Nasdaq:APRI) is a pharmaceutical company that has an approved product, Vitaros®, for the treatment of ED.
Aratana Therapeutics
Aratana Therapeutics develops innovative therapies for the animal health industry.
Attenua
Attenua, Inc. is a pharmaceutical company developing antitussive (anti-cough) medications.
Adial Pharmaceuticals
Adial Pharmaceuticals develops prescription medications for addiction and related disorders.
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Evecxia Therapeutics
Evecxia Therapeutics is a pharmaceutical company that is dedicated to realizing the therapeutic potential of 5-hydroxytryptophan.
Baudax Bio
Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.
TetraLogic Pharmaceuticals
TetraLogic Pharmaceuticals discovers and develops small molecule drugs for the treatment of debilitating diseases and conditions.
TARIS Biomedical
TARIS Biomedical is a pharmaceutical company developing therapies for genitourinary system issues.
TissueGene
TissueGene is a biopharmaceutical company focused on developing regenerative therapies for the treatment of various orthopedic disorders.
True North Therapeutics
True North Therapeutics is a pioneering biotechnology company selectively inhibiting the Complement pathway for diseases.
Terapio
Terapio is a biopharmaceutical company developing therapeutics based on the RLIP76 protein.
Trevi Therapeutics
Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Kiadis Pharma
Kiadis Pharma is a biopharmaceutical company offering novel treatment options for terminally ill cancer patients.
Koya Medical
Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.
Karuna Therapeutics
Karuna Therapeutics is a Massachusetts-based developer of drugs for the treatment of schizophrenia.
Wize Pharma
Wize Pharma is a pharmaceutical company that focuses on the treatment of ophthalmic disorders, including DES.
Sprout Pharmaceuticals
Sprout Pharmaceuticals is a medical company that develops products for the treatment of female sexual dysfunction.
Spring Bank Pharmaceuticals
Spring Bank Pharmaceuticals is a discovery company developing a new class of pharmaceuticals called small molecule nucleic acid hybrids.
Surface Ophthalmics
Surface Ophthalmics is a pharmaceutical company that develops therapeutics for the treatment of ocular diseases.
Sunesis Pharmaceuticals
Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Innate Pharma
Innate Pharma is a biopharmaceutical company developing immunotherapy drug candidates for the treatment of cancer and inflammatory diseases.
GH Research
GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.
Gene Sciences, Inc.
Gene Sciences Inc. is developing novel DNA targeted therapeutics for the treatment of human genetic diseases.
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Oyster Point Pharmaceuticals
Oyster is a clinical stage pharmaceutical company focused on the discovery development & commercialization .
Omeros
Omeros is a clinical-stage biopharmaceutical company developing products focused on inflammation and central nervous system disorders.
XyloCor Therapeutics
XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease.
Xeris Pharmaceuticals
Xeris Pharmaceuticals is a pharmaceutical company that develops therapies for patients in endocrinology, neurology, and gastroenterology.
CTI BioPharma
CTI BioPharma is a biopharmaceutical company developing oncology products for the treatment of cancer.
Cryosa
CryOSA is a medical device company developing novel treatments for obstructive sleep apnea.
Apollomics
Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.
Parnell Living Science
Parnell is a fully integrated pharmaceutical company dedicated to finding animal health solutions that matter.
Peptide Logic
Peptide Logic is a biopharmaceutical company developing peptide-antibody conjugates for pain.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-08-13 | Irisys | Irisys acquired by Recro Pharma | 50 M USD |
| 2015-04-13 | Alkermes | Alkermes acquired by Recro Pharma | N/A |
Investors List
Athyrium Capital Management LP
Athyrium Capital Management LP investment in Post-IPO Debt - Recro Pharma
Athyrium Capital Management LP
Athyrium Capital Management LP investment in Post-IPO Debt - Recro Pharma
Broadfin Capital
Broadfin Capital investment in Post-IPO Equity - Recro Pharma
Newest Events participated
Participated in American Association of Nurse Anesthetists (AANA) 2017 Annual Congress
on 2017-09-08 as exhibitor
Official Site Inspections
http://www.recropharma.com
- Host name: 138.197.48.70
- IP address: 138.197.48.70
- Location: Clifton United States
- Latitude: 40.8364
- Longitude: -74.1403
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07014
More informations about "Recro Pharma"
Recro Announces Name Change to Societal CDMO™ to Reflect …
Mar 21, 2022 · SAN DIEGO and GAINESVILLE, Ga., March 21, 2022 (GLOBE NEWSWIRE) — Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing …See details»
Societal™ CDMO
At Societal™ CDMO, we strive to be a preeminent partner to both our clients and our employees. As an organization, we are dedicated to working to improve the lives of patients everywhere. …See details»
Recro Pharma - Crunchbase Company Profile & Funding
Recro Pharma is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain, initially in the post-operative setting. The company's …See details»
Recro Announces Name Change to Societal CDMO to Reflect …
Mar 21, 2022 · SAN DIEGO and GAINESVILLE, Ga., March 21, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing …See details»
Recro Announces Name Change to Societal CDMO to Reflect
Mar 21, 2022 · SAN DIEGO and GAINESVILLE, Ga., March 21, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing …See details»
Recro Announces Name Change to Societal CDMO to Reflect …
Mar 24, 2022 · The name change reflects the expansion and transformation of the company as a result of the acquisition and integration of IriSys, a contract development and manufacturing …See details»
Recro Pharma rebrands itself as Societal CDMO in wake of Irisys ...
Mar 22, 2022 · Georgia-based CDMO Recro Pharma is rebranding itself as Societal CDMO in an effort to better communicate its services in the wake of a $50 million deal last summer for San …See details»
Recro Announces Executive Changes - GlobeNewswire
Dec 16, 2020 · Recro is a contract development and manufacturing organization, or CDMO, with integrated solutions for formulation, analytical services, regulatory support, manufacturing and …See details»
Recro Pharma, Inc. - VentureRadar
Since its inception in 1932, the group develops, produces and distributes a large range of products and solutions dedicated to serving the needs of dental professionals across the …See details»
Societal CDMO Reports Fourth Quarter and Full Year 2022 …
Mar 1, 2023 · organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today reported financial …See details»
Recro Pharma Careers - Levels.fyi
Everything you need to know about Recro Pharma including salaries, levels, benefits, and more.See details»
Recro Reports Fourth Quarter and Year End 2021 Financial
Mar 1, 2022 · Recro (NASD: REPH) is a bi-coastal contract development and manufacturing organization (CDMO) with capabilities spanning pre-Investigational New Drug (IND) …See details»
After acquisitions and new deals, Recro rebrands to Societal CDMO
Mar 21, 2022 · The team at Recro, a CDMO based out of Pennsylvania, has made a flurry of moves in the past year, expanding its operations to the … Sign up to read this article for free. …See details»
Societal CDMO Inc. - Cruelty Free Investing
The company is developing non-opioid products for treatment of serious acute pain. It offers drug solutions for cancer, musculoskeletal disorders and peripheral neuropathy, cancer …See details»
Recro Reports Progress Towards Launching Fill/Finish and
Feb 23, 2022 · SAN DIEGO, Calif. and GAINESVILLE, Ga., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing …See details»
Recro Pharma | REPH Stock Price, Company Overview & News
Today also marked the beginning of bank earnings season, with JPMorgan beating expectations on both earnings and revenues driven by a surge in trading revenue amid the market’s volatile …See details»
Recro Pharma, Inc. (REPH) CEO David Enloe on Q3 2021 Results
Nov 10, 2021 · Today, our organization has offerings in essentially all dosage forms for small molecule therapeutics, locations on both coasts of the U.S., a strong quality and regulatory …See details»
Recro Awarded Development and Manufacturing Contract by
Oct 20, 2021 · With an expertise in solving complex manufacturing problems, Recro is a leading CDMO providing therapeutic development, end-to-end regulatory support, clinical and …See details»
Recro Pharma, Inc. (REPH) CEO David Enloe on Q1 2021
May 9, 2021 · Today, we will be providing an overview of Recro's contract development and manufacturing business, including updates on corporate activities and financial results for the …See details»
Recro Wins $1.5 Million Formulation Development and CGMP
Jan 26, 2022 · Under terms of the new, multi-year, $1.5 million contract, the company will formulate, manufacture and supply a topical dermal drug product containing a prespecified …See details»